About

Mighty Capital is an early growth Silicon Valley Venture Capital firm that invests in companies building “products that count”: products that transform business and life at scale. We invest in companies that have:
  • A strong leadership team
  • Achieved product-market fit, and 
  • A clear go-to-market strategy
Our portfolio company, Amplitude, say that we bring the “best value for the dollar invested.”  The combination of our diverse partnership expertise and our exclusive access to Products That Count, the world's most influential network of product managers, produces unique and proprietary value to our portfolio. Products that count is over 200,000 product managers, which helps our companies:
  • Hire new talent,
  • Sell products,
  • Develop new ideas, and
  • Potentially exit via corporate sale, since it is often executive PMs who initiate M&A transactions
This unique value proposition is a prime reason why larger firms enjoy partnering with us - a startup venture firm, and why Business Insider says we've come up with “a new way of doing venture capital.”   If you or someone you know runs a company that meets those criteria, we’d love to hear about it! The best way to get in touch with us is via a mutual connection, most likely a current investor or your law firm. If that’s not an option, then email dealflow@mighty.capital.

Blog


September 4, 2017

A killer pitch deck sounds like a story by design. It is meant to help you step back from the details of your business or new product, to tell a compelling story to an investor. It reads as simple as this: “We are a unique team, excited to solve a big and hard problem. We came up with a sustainably differentiated solution. As a result, we are gaining solid traction, which we monetize fairly. So our financials look extremely promising but to get there, we need a reasonable amount of funding. We have a credible plan to generate significant returns for our investors.”

Read More

February 3, 2017

When a due diligence is appropriate, we ask the entrepreneur to make a data room available to the due diligence team. Through a review of the material in the data room and discussions with the CEO, exec team and references, the due diligence lead is able to cover the key aspects of the due diligence: team, business, financing, and match with Mighty Capital.

Read More

August 2, 2019

SC Moatti was honored to recently be interviewed by Innovation Hong Kong. Read about her experience, her thoughts on AI, and a few updates on Mighty Capital and Products That Count.

Read More

July 12, 2019

Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scale

Read More

June 27, 2019

An effective branding strategy requires seeing your entire constituent universe and transmitting a constant, cohesive and comprehensive values message.

Read More

May 21, 2019

Cancer is smart. Yes, you read that right.

The disease isn’t intelligent in the traditional sense — but cancer cells are adaptable, ‘learning’ from their environment and constantly evolving to improve survival. While targeted therapy can be effective at first, this evolution means that treatment resistance and disease progression remain a challenge.

To effectively combat cancer — to both detect it sooner and develop the most impactful, dynamic therapies — we need to be able to understand it. This means tracking the progression of each and every cancerous cell.

Read More

May 7, 2019

How top marketers are winning against digital-only disruptors by bringing location to the cloud.

Read More

May 3, 2019

Listen to the Product Guru Bruce Cleveland discuss the importance of Bridging The Traction Gap for startups and investors alike:

  • Building the framework for success factors that turn startups into sustainable businesses
  • What it takes for companies with promising tech to become industry powerhouses
  • The difference between seeking out investors and having investors come to you
Read More

April 24, 2019

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing as a first-line diagnostic test for critically ill babies.

Read More

April 12, 2019

Mighty Capital, whose founder and managing partner is SC Moatti, has its first liquidity event. SC tells Women’s PE Briefs that the firm sold a small portion of its first investment, Amplitude.

Read More

April 12, 2019

Hear from the leader as one of Mighty Capital’s portfolio companies share his experience delivering customer delight through product:

  • The power of authentic customer delight
  • Driving efficiencies for growth with a personal touch
  • Staying true to your company’s mission and core values

To effectively scale a business, it’s critical to focus on providing customer delight with marketing tactics that are rooted in the product’s core value.

Read More

April 4, 2019
Idea to IPO’s mission is to promote entrepreneurship, support entrepreneurs, build community, & provide value in the Silicon Valley startup ecosystem.
SC Moatti participated as a panelist during the 2/28/2019 Venture Capital Panel discussing the hottest funding trends of 2019.
Read More

© 2019 Mighty Capital All Rights Reserved